NCT05016232Completed
Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women
Developing and Pilot Testing an Adaptive Intervention to Facilitate PrEP Uptake and Maximize PrEP Adherence Among At-Risk Transgender Women
Source: ClinicalTrials.gov · Last updated 25 Jul 2024
Brief summary (registry, in English)
"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 123 (actual)
- First submitted
- 9 Aug 2021
- Start date
- 18 Oct 2022
- Primary completion date
- 31 May 2024
- Lead sponsor
- University of California, Los Angeles
- Diseases
- HIV
- NCT number
- NCT05016232
What you commit to
- Study type: Interventional
- Participants enrolled: 123
- From 18 Oct 2022 to the primary completion date, 31 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at time of visit
- Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of interview (these patients will be referred immediately for treatment, but may join the study when this is resolved)
Lab values
- Laboratory or clinical findings that would preclude PrEP initiation (e.g. Hepatitis B infection, decreased creatinine clearance)
Other
- Has lived in RI for less than three months (as a means to enhance participant retention)
Who the study is looking for
- Age: 18 years or older
- Male sex at birth
- Self-identify as a woman, a transgender woman, or another identity along the male-to-female gender spectrum
- PrEP naïve
- PrEP indicated per CDC guidelines (incl. HIV negative)
- Owns a cell phone or willing to use one in the study
- Able to understand and speak English or Spanish
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCLA Center for LGBTQ+ Advocacy, Research & Health Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.